12/11
12:30 pm
trml
Tourmaline Bio, Inc. (NASDAQ: TRML) had its "buy" rating re-affirmed by analysts at Guggenheim.
Low
Report
Tourmaline Bio, Inc. (NASDAQ: TRML) had its "buy" rating re-affirmed by analysts at Guggenheim.
12/11
11:29 am
trml
Tourmaline Bio, Inc. (NASDAQ: TRML) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $25.00 price target on the stock.
Low
Report
Tourmaline Bio, Inc. (NASDAQ: TRML) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $25.00 price target on the stock.
12/11
08:21 am
trml
Tourmaline Bio, Inc. (NASDAQ: TRML) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $49.00 price target on the stock.
Medium
Report
Tourmaline Bio, Inc. (NASDAQ: TRML) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $49.00 price target on the stock.
12/10
08:34 am
trml
Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day [Yahoo! Finance]
Low
Report
Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day [Yahoo! Finance]
12/10
08:30 am
trml
Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day
Medium
Report
Tourmaline Bio Highlights Cardiovascular Inflammation Focus and Announces Key Clinical and Strategic Updates at Investor Day
12/6
08:13 am
trml
Tourmaline Bio, Inc. (NASDAQ: TRML) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $50.00 price target on the stock.
Low
Report
Tourmaline Bio, Inc. (NASDAQ: TRML) is now covered by analysts at BMO Capital Markets. They set an "outperform" rating and a $50.00 price target on the stock.
11/14
07:39 am
trml
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024 [Yahoo! Finance]
Medium
Report
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024 [Yahoo! Finance]
11/14
07:30 am
trml
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024
Medium
Report
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024
11/13
09:50 am
trml
Prevent Blindness Declares Fifth Annual Thyroid Eye Disease Awareness Week as Nov. 18-24, 2024 [Yahoo! Finance]
Low
Report
Prevent Blindness Declares Fifth Annual Thyroid Eye Disease Awareness Week as Nov. 18-24, 2024 [Yahoo! Finance]
11/13
02:07 am
trml
Tourmaline Bio, Inc. Reports Third Quarter Financial Results [Yahoo! Finance]
Low
Report
Tourmaline Bio, Inc. Reports Third Quarter Financial Results [Yahoo! Finance]
11/11
12:13 pm
trml
Tourmaline Bio, Inc. (NASDAQ: TRML) had its price target raised by analysts at HC Wainwright from $48.00 to $49.00. They now have a "buy" rating on the stock.
Low
Report
Tourmaline Bio, Inc. (NASDAQ: TRML) had its price target raised by analysts at HC Wainwright from $48.00 to $49.00. They now have a "buy" rating on the stock.
11/7
07:30 am
trml
Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Low
Report
Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
10/31
07:30 am
trml
Tourmaline Bio to Present at Upcoming Investor Conferences
Medium
Report
Tourmaline Bio to Present at Upcoming Investor Conferences
10/16
08:10 am
trml
Keros Therapeutics names Yung Chyung as chief medical officer [Seeking Alpha]
Medium
Report
Keros Therapeutics names Yung Chyung as chief medical officer [Seeking Alpha]
10/16
07:43 am
trml
Tourmaline Bio, Inc. (NASDAQ: TRML) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
Medium
Report
Tourmaline Bio, Inc. (NASDAQ: TRML) was upgraded by analysts at Cantor Fitzgerald to a "strong-buy" rating.
10/15
07:30 am
trml
Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024
Low
Report
Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024
10/11
07:45 am
trml
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress [Yahoo! Finance]
Medium
Report
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress [Yahoo! Finance]
10/11
07:30 am
trml
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress
Medium
Report
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress
10/8
07:30 am
trml
Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board
Medium
Report
Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board